Long ‐term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial
ConclusionsThis study demonstrated low persistence rates over 12 months for both mirabegron and solifenacin, although the reasons for discontinuation were somewhat different.
Source: LUTS: Lower Urinary Tract Symptoms - Category: Urology & Nephrology Authors: Manami KINJO, Yuki SEKIGUCHI, Yasukuni YOSHIMURA, Kikuo NUTAHARA Tags: ORIGINAL ARTICLE Source Type: research
More News: Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology | VESIcare | Women